The American Cancer Society recommends prostate-specific antigen (PSA) testing for men aged 50 to 70. While some doctors may discourage PSA testing, it’s still an essential tool for early detection and treatment of prostate cancer.
The PSA test is not foolproof, as it can produce false positives leading to unnecessary surgeries. However, careful testing, including imaging, biopsy, and genetic analysis, helps separate high-risk from low-risk cancers. This approach ensures that only rare, aggressive tumors receive attention while sparing healthy men from invasive procedures.
It’s essential to note that PSA testing is not age-specific; 53-year-olds can also benefit from screening. Men with a family history, Black men, and those with certain genetic risks may need to start screening earlier or later than others.
The digital rectal exam (DRE) has limited value in screening for prostate cancer. While it’s essential for some men, the test is not as accurate as previously thought, with 90% of abnormal exams being false positives. A discussion with a doctor about PSA testing and its limitations can help patients make informed decisions about their care.
In summary, while there are valid concerns about PSA testing, it remains an essential tool in prostate cancer screening. A balanced approach that combines thorough testing with clear communication between doctors and patients is key to early detection and effective treatment of prostate cancer.
Source: https://www.oregonlive.com/advice/2025/06/dear-doctor-do-psa-tests-produce-false-positives-that-lead-to-unnecessary-procedures.html